A PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT

被引：0
|
作者：
Fogh, Shannon E.
Machtay, Mitchell
Werner-Wasik, Maria
Curran, Walter
Bonanni, Roseann
Axelrod, Rita
Andrews, David W.
Dicker, Adam P.
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 663
页数：1
相关论文
共 50 条
  • [1] A phase I trial using patupilone (epothilone B) and concurrent radiotherapy for CNS malignancies
    Fogh, S. E.
    Machtay, M.
    Werner-Wasik, M.
    Curran, W.
    Bonanni, R.
    Mallon, G.
    Axelrod, R.
    Andrews, D.
    Dicker, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] A phase I trial of patupilone (Epothilone B) and concurrent radiotherapy for CNS malignancies
    Machtay, M.
    Curran, W. J.
    Werner-Wasik, M.
    Mallon, G.
    Axelrod, R.
    Andrews, D.
    Dicker, A. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S244 - S245
  • [3] PHASE I TRIAL USING PATUPILONE (EPOTHILONE B) AND CONCURRENT RADIOTHERAPY FOR CENTRAL NERVOUS SYSTEM MALIGNANCIES
    Fogh, Shannon
    Machtay, Mitchell
    Werner-Wasik, Maria
    Curran, Walter J., Jr.
    Bonanni, Roseann
    Axelrod, Rita
    Andrews, David
    Dicker, Adam P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04): : 1009 - 1016
  • [4] Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial
    Oehler, Christoph
    Frei, Karl
    Rushing, Elisabeth J.
    McSheehy, Paul M. J.
    Weber, Dirk
    Allegrini, Peter R.
    Weniger, Dorothea
    Luetolf, Urs M.
    Knuth, Alexander
    Yonekawa, Yasuhiro
    Barath, Krisztina
    Broggini-Tenzer, Angela
    Pruschy, Martin
    Hofer, Silvia
    ONCOLOGY, 2012, 83 (01) : 1 - 9
  • [5] The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells
    Oehler, Christoph
    von Bueren, Andre O.
    Furmanova, Polina
    Broggini-Tenzer, Angela
    Orlowski, Katrin
    Rutkowski, Stefan
    Frei, Karl
    Grotzer, Michael A.
    Pruschy, Martin
    NEURO-ONCOLOGY, 2011, 13 (09) : 1000 - 1010
  • [6] A phase I and pharmacologic trial of weekly epothilone B in patients with advanced malignancies.
    Oza, A
    Zamek, RM
    Siu, L
    Locsin, SM
    Moore, M
    Chen, F
    Chen, TL
    Cohen, P
    Rothermel, J
    Rubin, E
    ANNALS OF ONCOLOGY, 2000, 11 : 133 - 133
  • [7] THE MICROTUBULE STABILIZER PATUPILONE (EPOTHILONE B) IS A POTENT RADIOSENSITIZER IN MEDULLOBLASTOMA CELLS
    Oehler, C.
    von Bueren, A. O.
    Furmanova, P.
    Rutkowski, S.
    Frei, K.
    Grotzer, M. A.
    Pruschy, M.
    NEURO-ONCOLOGY, 2010, 12 (06) : II88 - II88
  • [8] Use of Epothilone B (Patupilone) in Refractory Lymphoma and Advanced Solid Tumors in Dogs
    Meier, V.
    Geigy, C.
    Grosse, N.
    McSheehy, P.
    Bley, C. Rohrer
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2013, 27 (01) : 120 - 125
  • [9] Phase I trial of patupilone plus carboplatin in patients with advanced cancer
    Gore, Martin
    Kaye, Stan
    Oza, Amit
    Keyzor, Carmel
    Pyle, Linda
    Pereno, Raffaele
    Sklenar, Ivo
    Johri, Anandhi
    ANNALS OF ONCOLOGY, 2004, 15 : 126 - 127
  • [10] Phase I clinical trial of BMS-247550, a derivative of epothilone B, using accelerated titration 213 design
    Gadgeel, SM
    Wozniak, A
    Boinpally, RR
    Wiegand, R
    Heilbrun, LK
    Jain, V
    Parchment, R
    Colevas, D
    Cohen, MB
    LoRusso, PM
    CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6233 - 6239
12345